SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Jul 5, 2017
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: July 5, 2017 · CIK: 0001585608 · Accession: 0001104659-17-043473
AI Filing Summary & Sentiment
File numbers found in text: 333-217364
Show Raw Text
CORRESP 1 filename1.htm July 5, 2017 Via Email and EDGAR Suzanne Hayes Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Animal Health, Inc. Registration Statement on Form S-4 File No. 333-217364 Ladies and Gentlemen: Jaguar Animal Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-4 (as amended, the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on July 6, 2017, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable. Please confirm effectiveness by advising our counsel, Donald C. Reinke of Reed Smith LLP, at (650) 352-0532. Very truly yours, Jaguar Animal Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Animal Health, Inc. · 201 Mission Street, Suite 2375 • San Francisco, CA 94105 Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 • www.jaguaranimalhealth.com